Celon Pharma S.A. at the 2018 BIO International Convention

Between 4 and 7 June this year, representatives of our Company are taking part in the largest global Life Sciences networking meeting. Our participation at this event is one of the elements of our implementing our strategy to increase Celon Pharma’s international presence and our planned global commercialisation of the Company’s innovative portfolio.

Bogdan Manowski, Director for Business Development, Member of the Board of Celon Pharma S.A. Our presence every year is an expression of our consistent strategy to increase Celon Pharma’s international presence in connection with a very dynamic development of our innovative product portfolio.as well as advanced business plans in the US market of inhalation drugs. We are counting on interesting and inspiring meetings with representatives of the industry, which in the long run will translate into successful commercialisation of our candidates for new drugs on a global scale.4